Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML	Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1	2026-09-17		NCT06786533

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Hemogenyx Pharmaceuticals LLC	1
M.D. Anderson Cancer Center	1145

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
MD Anderson	Houston	United States	56

Clinical trials